ADHD Prevalence Statistics: Rates in Children vs. Adults by Gender

ADHD is one of the most common neurodevelopmental disorders. Prevalence estimates vary by diagnostic criteria, methodology, and population.

US Children (CDC/NSCH Data)

• Ever diagnosed: 11.3% (ages 3–17) ≈ 7 million (2022)
• Current ADHD: 9.8% (6.4 million)
• Gender: Boys 13.5% vs. Girls 5.7% (2.4:1 ratio)
• Age: 12–17 years highest (13.4%); 3–5 years lowest (2.4%)
• Race/Ethnicity: White 11.6%, Black 10.8%, Hispanic 7.3%, Asian 3.2%
• Insurance: Public 12.7% vs. Private 8.6% vs. Uninsured 6.3%
• Severity: Mild 41%, Moderate 39%, Severe 19%

US Adults

• Current prevalence: 4.4% (10.5 million)—likely underdiagnosed
• Gender: Men 5.4% vs. Women 3.2% (narrower than childhood)
• Persistence: 50–65% childhood ADHD → adult ADHD
• Late diagnosis: Increasing (especially women, high-IQ, inattentive type)

Global Variation

• Pooled prevalence: ~5–7% children (DSM-IV); ~2.5% adults
• Higher in North America vs. Europe/Africa/Asia (diagnostic intensity, not biology)
• ICD-10 (HKD) stricter → lower rates than DSM-5

Comorbidity Impact

• ODD: 40–60%
• Anxiety: 25–35%
• Depression: 15–30%
• Learning disabilities: 20–30%
• Substance use: 2× risk (untreated)

Diagnostic Trends

• Increasing recognition of inattentive presentation (especially girls/women)
• Adult ADHD clinics proliferating
• Telehealth expanded access (and overdiagnosis concerns)
• Stimulant prescriptions increased 45% (2012–2022)

Prevalence reflects both true biology and detection intensity. Accurate diagnosis requires multi-informant, multi-setting assessment.